Artificial intelligence is rapidly acquiring a reputation as an unreliable, even dangerous, force in medicine and drug development. Hallucinations, opaque decision-making, and high-profile failures have fueled resistance to its adoption across health care systems. But this backlash reflects not an inherent flaw in AI itself, it reflects how we are choosing to use it. The
Read more…
The real problem with AI in medicine and drug development originally appeared in KevinMD.com.
Join the Fight Against Chronic Pain: It’s Time for Breakthrough Legislation in Congress
Over the past 15 years, financial and administrative barriers – most notably step therapy mandates and prior authorization requirements – have repeatedly forced patients through
